Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016

Publisher Name :
Date: 12-Oct-2016
No. of pages: 103
Inquire Before Buying

This report

Mainly covers the following product types

- Exenatied

- Liraglutide

- Lixisenatide

- Albiglutide

- Dulaglutide

The segment applications including

- Hospital

- Pharmacy

- Other

Segment regions including (the separated region report can also be offered)

- North America

- Europe

- China

- Asia (Ex. China)

- Other

The players list (Partly, Players you are interested in can also be added)

- Novo Nordisk

- AstraZeneca

- Eli Lily

- GSK

- Sanofi

- Bristol-Myers Squibb

- Amylin

With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016

Table of Contents
1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists
1.1 Definition and Specifications of Glucagon like peptide-1 (GLP-1) agonists
1.1.1 Definition of Glucagon like peptide-1 (GLP-1) agonists
1.1.2 Specifications of Glucagon like peptide-1 (GLP-1) agonists
1.2 Classification of Glucagon like peptide-1 (GLP-1) agonists
1.2.1 Exenatied
1.2.2 Liraglutide
1.2.3 Lixisenatide
1.2.4 Albiglutide
1.2.5 Dulaglutide
1.3 Applications of Glucagon like peptide-1 (GLP-1) agonists
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Industry Chain Structure of Glucagon like peptide-1 (GLP-1) agonists
1.5 Industry Overview and Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists
1.5.1 Industry Overview of Glucagon like peptide-1 (GLP-1) agonists
1.5.2 Global Major Regions Status of Glucagon like peptide-1 (GLP-1) agonists
1.6 Industry Policy Analysis of Glucagon like peptide-1 (GLP-1) agonists
1.7 Industry News Analysis of Glucagon like peptide-1 (GLP-1) agonists
2 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.1 Raw Material Suppliers and Price Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.2 Equipment Suppliers and Price Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.3 Labor Cost Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.4 Other Costs Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.5 Manufacturing Cost Structure Analysis of Glucagon like peptide-1 (GLP-1) agonists
2.6 Manufacturing Process Analysis of Glucagon like peptide-1 (GLP-1) agonists
3 Technical Data and Manufacturing Plants Analysis of Glucagon like peptide-1 (GLP-1) agonists
3.1 Capacity and Commercial Production Date of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Glucagon like peptide-1 (GLP-1) agonists Major Manufacturers in 2015
4 Global Glucagon like peptide-1 (GLP-1) agonists Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Capacity and Growth Rate Analysis
4.2.2 2015 Glucagon like peptide-1 (GLP-1) agonists Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Sales and Growth Rate Analysis
4.3.2 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Sales Price
4.4.2 2015 Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Glucagon like peptide-1 (GLP-1) agonists Gross Margin
4.5.2 2015 Glucagon like peptide-1 (GLP-1) agonists Gross Margin Analysis (Company Segment)
5 Glucagon like peptide-1 (GLP-1) agonists Regional Market Analysis
5.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.1.1 North America Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.1.2 North America 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.1.4 North America 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.2 Europe Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.2.1 Europe Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.2.2 Europe 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.2.4 Europe 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.3 China Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.3.1 China Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.3.2 China 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.3.4 China 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.4 Asia (Ex. China) Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.4.1 Asia (Ex. China) Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.4.2 Asia (Ex. China) 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Asia (Ex. China) 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.4.4 Asia (Ex. China) 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
5.5 Other Glucagon like peptide-1 (GLP-1) agonists Market Analysis
5.5.1 Other Glucagon like peptide-1 (GLP-1) agonists Market Overview
5.5.2 Other 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Other 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales Price Analysis
5.5.4 Other 2015 Glucagon like peptide-1 (GLP-1) agonists Market Share Analysis
6 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Segment Market Analysis (by Type)
6.1 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Sales by Type
6.2 Different Types Glucagon like peptide-1 (GLP-1) agonists Product Interview Price Analysis
6.3 Different Types Glucagon like peptide-1 (GLP-1) agonists Product Driving Factors Analysis
6.3.1 Exenatied Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.2 Liraglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.3 Lixisenatide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.4 Albiglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
6.3.5 Dulaglutide Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
7 Global 2011-2016E Glucagon like peptide-1 (GLP-1) agonists Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
7.3.2 Pharmacy Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
7.3.3 Other Glucagon like peptide-1 (GLP-1) agonists Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Glucagon like peptide-1 (GLP-1) agonists
8.1 Novo Nordisk
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Novo Nordisk 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Novo Nordisk 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.2 AstraZeneca
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 AstraZeneca 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 AstraZeneca 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.3 Eli Lily
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Eli Lily 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Eli Lily 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.4 GSK
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 GSK 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 GSK 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.5 Sanofi
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Sanofi 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Sanofi 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.6 Bristol-Myers Squibb
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Bristol-Myers Squibb 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bristol-Myers Squibb 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
8.7 Amylin
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Amylin 2015 Glucagon like peptide-1 (GLP-1) agonists Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Amylin 2015 Glucagon like peptide-1 (GLP-1) agonists Business Region Distribution Analysis
…
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.2 Europe 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.3 China 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.4 Asia (Ex. China) 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.2.5 Other 2016-2021 Glucagon like peptide-1 (GLP-1) agonists Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Glucagon like peptide-1 (GLP-1) agonists Marketing Model Analysis
10.1 Glucagon like peptide-1 (GLP-1) agonists Regional Marketing Model Analysis
10.2 Glucagon like peptide-1 (GLP-1) agonists International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Glucagon like peptide-1 (GLP-1) agonists by Regions
10.4 Glucagon like peptide-1 (GLP-1) agonists Supply Chain Analysis
11 Consumers Analysis of Glucagon like peptide-1 (GLP-1) agonists
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists
12.1 New Project SWOT Analysis of Glucagon like peptide-1 (GLP-1) agonists
12.2 New Project Investment Feasibility Analysis of Glucagon like peptide-1 (GLP-1) agonists
13 Conclusion of the Global Glucagon like peptide-1 (GLP-1) agonists Market Professional Survey Report 2016
  • Europe Fibromyalgia Drugs Market Report 2016
    Published: 06-Dec-2016        Price: US 3900 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Fibromyalgia Drugs Revenue, means the sales value of Fibromyalgia Drugs This report studies sales (consumption) of Fibromyalgia Drugs in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Eli Lilly - Forest Laboratories - .........
  • Europe Alzheimer's Disease Drug Market Report 2016
    Published: 06-Dec-2016        Price: US 3900 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Alzheimer's Disease Drug Revenue, means the sales value of Alzheimer's Disease Drug This report studies sales (consumption) of Alzheimer's Disease Drug in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Eisai - Pfizer - Decartis - Sh......
  • United States Collagen Medical Adhesive Market Report 2016
    Published: 06-Dec-2016        Price: US 3800 Onwards        Pages: 98
    Notes: Sales, means the sales volume of Collagen Medical Adhesive Revenue, means the sales value of Collagen Medical Adhesive This report studies sales (consumption) of Collagen Medical Adhesive in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Ethicon (Johnson & Johnson) - Covidien - B. Braun - Henkel AG & Company - GEM S.R.L. - GluStitch - Bax......
  • Global Spinal biologics Sales Market Report 2016
    Published: 06-Dec-2016        Price: US 4000 Onwards        Pages: 119
    Notes: Sales, means the sales volume of Spinal biologics Revenue, means the sales value of Spinal biologics This report studies sales (consumption) of Spinal biologics in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Zimmer Holding, Inc. - Depuy Synthes - Medtronic, Inc. (U.S.) - Nu......
  • Europe Thebaine Market Report 2016
    Published: 06-Dec-2016        Price: US 3900 Onwards        Pages: 114
    Notes: Sales, means the sales volume of Thebaine Revenue, means the sales value of Thebaine This report studies sales (consumption) of Thebaine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Mallinckrodt Pharmaceuticals - Noramco - Alcaliber - Tasmanian Alkaloids......
  • Global Multiple Myeloma Drugs Market Professional Survey Report 2016
    Published: 06-Dec-2016        Price: US 3500 Onwards        Pages: 114
    Notes: Production, means the output of Multiple Myeloma Drugs Revenue, means the sales value of Multiple Myeloma Drugs This report studies Multiple Myeloma Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, ......
  • Global Typhoid Fever Vaccine Sales Market Report 2016
    Published: 06-Dec-2016        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Typhoid Fever Vaccine Revenue, means the sales value of Typhoid Fever Vaccine This report studies sales (consumption) of Typhoid Fever Vaccine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Sanofi-Pasteur - Beijing Tiantan Biological Products - Sh......
  • Global Tuberculosis Vaccine Sales Market Report 2016
    Published: 06-Dec-2016        Price: US 4000 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Tuberculosis Vaccine Revenue, means the sales value of Tuberculosis Vaccine This report studies sales (consumption) of Tuberculosis Vaccine in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GSK - Sanofi-Pasteur - Beijing Tiantan Biological Products ......
  • Global Thrombin (Human) Sales Market Report 2016
    Published: 06-Dec-2016        Price: US 4000 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Thrombin (Human) Revenue, means the sales value of Thrombin (Human) This report studies sales (consumption) of Thrombin (Human) in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Baxter - CSL - Bayer - Grifols - Octapharma - Shangh......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs